NABRIVA THERAPEUTICS PLC's ticker is and the CUSIP is G63637113. A total of 32 filers reported holding NABRIVA THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 45,849 | $8,000 | 0.60% |
Aisling Capital Management LP | 90,000 | $16,000 | 0.01% |
Frazier Life Sciences Management, L.P. | 425,650 | $77,000 | 0.01% |
Values First Advisors, Inc. | 43,728 | $8,000 | 0.01% |
Virtu Financial LLC | 127,585 | $23,000 | 0.00% |
CCG WEALTH MANAGEMENT, LLC | 10,000 | $2,000 | 0.00% |
Running Point Capital Advisors, LLC | 10,000 | $2,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 125 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 42,738 | $7,000 | 0.00% |